Carboxymethyl-Dextran-Coated Superparamagnetic Iron Oxide Nanoparticles for Drug Delivery: Influence of the Coating Thickness on the Particle Properties.
agglomeration behavior
antimicrobial peptide
carboxymethyl dextran
iron oxide nanoparticles
magnetically controlled drug delivery
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
25 Nov 2022
25 Nov 2022
Historique:
received:
08
11
2022
revised:
18
11
2022
accepted:
21
11
2022
entrez:
11
12
2022
pubmed:
12
12
2022
medline:
15
12
2022
Statut:
epublish
Résumé
Carboxymethyl-dextran (CMD)-coated iron oxide nanoparticles (IONs) are of great interest in nanomedicine, especially for applications in drug delivery. To develop a magnetically controlled drug delivery system, many factors must be considered, including the composition, surface properties, size and agglomeration, magnetization, cytocompatibility, and drug activity. This study reveals how the CMD coating thickness can influence these particle properties. ION@CMD are synthesized by co-precipitation. A higher quantity of CMD leads to a thicker coating and a reduced superparamagnetic core size with decreasing magnetization. Above 12.5−25.0 g L−1 of CMD, the particles are colloidally stable. All the particles show hydrodynamic diameters < 100 nm and a good cell viability in contact with smooth muscle cells, fulfilling two of the most critical characteristics of drug delivery systems. New insights into the significant impact of agglomeration on the magnetophoretic behavior are shown. Remarkable drug loadings (62%) with the antimicrobial peptide lasioglossin and an excellent efficiency (82.3%) were obtained by covalent coupling with the EDC/NHS (N-ethyl-N′-(3-(dimethylamino)propyl)carbodiimide/N-hydroxysuccinimide) method in comparison with the adsorption method (24% drug loading, 28% efficiency). The systems showed high antimicrobial activity with a minimal inhibitory concentration of 1.13 µM (adsorption) and 1.70 µM (covalent). This system successfully combines an antimicrobial peptide with a magnetically controllable drug carrier.
Identifiants
pubmed: 36499070
pii: ijms232314743
doi: 10.3390/ijms232314743
pmc: PMC9740466
pii:
doi:
Substances chimiques
ferumoxides
G6N3J05W84
Dextrans
0
Magnetite Nanoparticles
0
Drug Carriers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Science Foundation Ireland
ID : 12/RI/2345/SOF
Pays : Ireland
Organisme : International Graduate School of Science and Engineering
ID : 14.04
Références
Neuroimage. 2021 Sep;238:118213
pubmed: 34116153
Ann N Y Acad Sci. 2014 Apr;1313:35-56
pubmed: 24673240
Biomater Res. 2021 Apr 21;25(1):12
pubmed: 33883044
Materials (Basel). 2021 Jan 06;14(2):
pubmed: 33419055
Eur J Pharm Biopharm. 2013 Aug;84(3):445-8
pubmed: 23333302
Chem Rev. 2008 Jun;108(6):2064-110
pubmed: 18543879
Nanomedicine (Lond). 2018 Jul;13(13):1513-1516
pubmed: 29998779
Int J Mol Sci. 2021 Mar 11;22(6):
pubmed: 33799744
Br J Cancer. 1991 Sep;64(3):425-7
pubmed: 1911181
Nanoscale Adv. 2020 Aug 17;2(10):4510-4521
pubmed: 36132895
Sci Rep. 2018 Feb 1;8(1):2082
pubmed: 29391477
Artif Cells Nanomed Biotechnol. 2017 Jun;45(4):833-842
pubmed: 27247194
J Colloid Interface Sci. 2009 Oct 1;338(1):56-62
pubmed: 19635622
Angew Chem Int Ed Engl. 2007;46(8):1222-44
pubmed: 17278160
Colloids Surf B Biointerfaces. 2013 Feb 1;102:37-44
pubmed: 23000675
Biotechnol Adv. 2014 Jul-Aug;32(4):711-26
pubmed: 24252561
J Nanosci Nanotechnol. 2011 Dec;11(12):11089-94
pubmed: 22409062
AAPS J. 2016 Nov;18(6):1576-1582
pubmed: 27527889
Nat Nanotechnol. 2013 Oct;8(10):772-81
pubmed: 24056901
Sci Rep. 2020 Jun 15;10(1):9664
pubmed: 32541900
J Nanopart Res. 2013 Aug 1;15(8):1874
pubmed: 24470787
Nanoscale. 2016 Dec 1;8(47):19421-19474
pubmed: 27812592
Angew Chem Int Ed Engl. 2014 Nov 10;53(46):12320-64
pubmed: 25294565
ACS Appl Mater Interfaces. 2018 Mar 14;10(10):9094-9103
pubmed: 29473734
Molecules. 2012 Oct 18;17(10):12276-86
pubmed: 23079498
Biomaterials. 2011 Dec;32(35):9353-63
pubmed: 21911254
Sci Rep. 2019 Mar 1;9(1):3232
pubmed: 30824719
Appl Microbiol Biotechnol. 2015 Mar;99(5):2065-82
pubmed: 25616529
Int J Biol Macromol. 2010 Nov 1;47(4):570-7
pubmed: 20713081
Nanomedicine (Lond). 2017 Jul;12(13):1533-1546
pubmed: 28621578
Colloids Surf B Biointerfaces. 2014 Dec 1;124:17-24
pubmed: 24656615
Biomaterials. 2008 Apr;29(12):1912-9
pubmed: 18242692
NDT Plus. 2010 Aug;3(4):341-2
pubmed: 25949425
Contrast Media Mol Imaging. 2011 Jul-Aug;6(4):314-27
pubmed: 21861291
Chembiochem. 2009 Aug 17;10(12):2089-99
pubmed: 19591185
Int J Nanomedicine. 2008;3(2):169-80
pubmed: 18686777
Heliyon. 2020 Apr 15;6(4):e03784
pubmed: 32322741
Int J Nanomedicine. 2012;7:3503-16
pubmed: 22848174
Arch Gerontol Geriatr. 2000 Aug 1;31(1):35-42
pubmed: 10989162
Biotechnol Adv. 2013 Dec;31(8):1224-36
pubmed: 23528431
Nat Nanotechnol. 2009 May;4(5):325-30
pubmed: 19421220
Front Chem. 2018 Aug 20;6:360
pubmed: 30177965
Sci Technol Adv Mater. 2015 Apr 28;16(2):023501
pubmed: 27877761
Adv Sci (Weinh). 2021 Feb 25;8(9):2003535
pubmed: 33977050
Nat Nanotechnol. 2016 Oct 5;11(10):828-834
pubmed: 27703248
Macromol Biosci. 2010 Feb 11;10(2):211-20
pubmed: 19904721
Crit Rev Biotechnol. 2016;36(1):43-58
pubmed: 25025272
Small. 2014 Mar 12;10(5):835-53
pubmed: 24123934
Pharmaceuticals (Basel). 2021 Apr 24;14(5):
pubmed: 33923229
ACS Appl Mater Interfaces. 2021 May 5;13(17):20830-20844
pubmed: 33884871
Acc Chem Res. 2011 Oct 18;44(10):853-62
pubmed: 21528865
Pathol Biol (Paris). 2014 Apr;62(2):100-7
pubmed: 24674658
Langmuir. 2010 Nov 16;26(22):16745-53
pubmed: 20879747
J Nanosci Nanotechnol. 2011 Nov;11(11):10187-92
pubmed: 22413363
ACS Nano. 2011 Feb 22;5(2):1428-35
pubmed: 21284377
Regul Toxicol Pharmacol. 2013 Feb;65(1):119-25
pubmed: 23200793
Colloids Surf B Biointerfaces. 2012 Jan 1;89:117-25
pubmed: 21962947
Int J Nanomedicine. 2014 Aug 05;9:3659-76
pubmed: 25120363
J Biomed Mater Res. 1999 Sep 15;46(4):531-8
pubmed: 10398014
Annu Rev Biomed Eng. 2012;14:1-16
pubmed: 22524388